Cibus (CBUS) Interest Coverage Ratio (2016 - 2026)
Cibus (CBUS) posted Interest Coverage Ratio of 17.8 for Q4 2025, down 5281.21% sequentially from 0.33 in Q3 2025, and up 51.8% YoY from 11.73 in Q4 2024.
Cibus (CBUS) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
Cibus has reported Interest Coverage Ratio for 10 years, with the latest figure at 17.8 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 51.8% year-over-year to 17.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 19.85 (up 71.44% YoY) and the FY2025 annual result came in at 0.54, up 78.5% from the prior year.
- Interest Coverage Ratio fell to 17.8 in Q4 2025 per CBUS's latest filing, from 0.33 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.33 in Q3 2025 and troughed at 335.03 in Q3 2023.
- A 5-year average of 44.42 and a median of 18.33 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio sank 1405.62% in 2023, then soared 97.36% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 18.85 in 2021, then tumbled by 147.57% to 46.66 in 2022, then tumbled by 87.39% to 87.44 in 2023, then jumped by 57.76% to 36.93 in 2024, then soared by 51.8% to 17.8 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 17.8, 0.33, and 0.79 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.30 |
| Dec 31, 2025 | -17.80 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.79 |
| Mar 31, 2025 | -1.84 |
| Dec 31, 2024 | -36.93 |
| Sep 30, 2024 | -12.55 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -1.88 |
| Dec 31, 2023 | -87.44 |
| Sep 30, 2023 | -335.03 |
| Jun 30, 2023 | -10.54 |
| Mar 31, 2023 | -61.99 |
| Dec 31, 2022 | -46.66 |
| Sep 30, 2022 | -88.61 |
| Jun 30, 2022 | -99.49 |
| Mar 31, 2022 | -4.12 |
| Dec 31, 2021 | -18.85 |
| Sep 30, 2021 | -19.54 |
| Jun 30, 2021 | -16.67 |